Fiserv (FISV) Beats on Q3 Earnings & Revenues, Tweaks View
Fiserv's (FISV) third-quarter 2021 earnings and revenues improve year over year.
Fiserv, Inc. FISV reported solid third-quarter 2021 results, wherein the company’s earnings and revenues surpassed the Zacks Consensus Estimate.
Adjusted earnings per share of $1.47 beat the consensus mark by 2.1% and increased 22.5% year over year. Adjusted revenues of $3.96 billion beat the consensus estimate by 0.03% and increased 10.4% year over year.
Internal revenue growth was 10% in the reported quarter, led by 18% growth in the Acceptance segment, 4% growth in the Fintech segment and 6% growth in the Payments segment.
So far this year, shares of Fiserv have declined 3.5% against 14% loss of the industry it belongs. The Zacks S&P 500 composite grew 22.6% in the same time frame.
Image Source: Zacks Investment Research
Let’s check out the numbers in detail:
Revenues in Detail
Revenues at the Merchant Acceptance segment came in at $1.72 billion, up 18% year over year. Adjusted revenues of $1.72 billion grew 17.9% year over year.
Revenues at the Payments and Network segment increased 6.1% year over year to $1.47 billion. Adjusted revenues of $1.48 billion grew 5.9% year over year.
Revenues at the Financial Technology segment increased 4.7% year over year to $761 million.
Revenues at the Total processing and services segment increased 8.1% year over year to $3.41 billion while product revenues grew 19.4% year over year to $756 million.
Adjusted operating income of $1.31 billion was up 41.2% from the year-ago quarter. Adjusted operating margin of 34.2% grew 130 basis points (bps) year over year.
Adjusted operating income at the Merchant Acceptance segment was $552 million, up 29.9% year over year. Adjusted operating margin grew to 32.2% from 29.2% in the year-ago quarter.
Adjusted operating income at the Payments and Network segment was $650 million, up 6.9% year over year. Adjusted operating margin grew to 44% from 43.5% in the year-ago quarter.
Operating income at the Financial Technology segment totaled $275 million, up 3.8% year over year. Operating margin fell to 36% from 36.4% in the year-ago quarter.
Balance Sheet and Cash Flow
Fiserv exited third-quarter 2021 with cash and cash equivalents of $933 million compared with $841 million at the end of the prior quarter. Long-term debt was $20.5 billion compared with $20.4 billion at the end of the prior quarter.
The company generated $678 million of net cash from operating activities in the reported quarter. Free cash flow was $572 million. Capital expenditures were $320 million.
The company repurchased 3.2 million shares for $365 million in the reported quarter.
Fiserv has raised the lower end of its outlook for 2021. Adjusted earnings per share are now anticipated in the range of $5.55 to $5.60 compared with the prior guidance of $5.50 and $5.60. The Zacks Consensus Estimate of $5.56 lies within the updated guidance.
The company now expects internal revenue growth of 11% compared with the prior guidance of 10% to 12%.
Currently, Fiserv carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Business Services Companies
Equifax’s EFX third-quarter 2021 adjusted earnings of $1.85 per share beat the Zacks Consensus Estimate by 7.6% but declined on a year-over-year basis. Revenues of $1.22 billion outpaced the consensus estimate by 3.6% and improved 14.5% year over year on a reported basis and 14% on a local-currency basis.
IQVIA’s IQV third-quarter 2021 adjusted earnings per share of $2.17 beat the consensus mark by 1.9% and improved 33.1% on a year-over-year basis. Total revenues of $3.39 billion outpaced the consensus estimate by 1% and increased 21.7% year over year on a reported basis and 21.1% on constant-currency basis.
Omnicom’s OMC third-quarter 2021 adjusted earnings of $1.65 per share that beat the consensus mark by 20.4% and increased 36.4% year over year. Total revenues of $3.4 billion surpassed the consensus estimate by 0.6% and increased 7.1% year over year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Omnicom Group Inc. (OMC): Free Stock Analysis Report
Fiserv, Inc. (FISV): Free Stock Analysis Report
Equifax, Inc. (EFX): Free Stock Analysis Report
IQVIA Holdings Inc. (IQV): Free Stock Analysis Report
To read this article on Zacks.com click here.